Ashoke Khanwalkar, MD
Otolaryngology · Aurora
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · University Physicians Incorporated · National Jewish Health
Hospitals listed: Intermountain Health Saint Joseph Hospital · National Jewish Health · University of Colorado Hospital Authority. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Khanwalkar’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A170474 · Current
Licensed to practise in California · since 2020 · expires 2028-10-31 · University of Chicago, Pritzker School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
3 licences
- Colorado CDR.1509CDR · since 2022 · expires 2027-04-30ActiveNo board action on this licenceCheck it with the stateWhat they told the state about themselves
- Illinois 036153049Licensed Physician And Surgeon · since 2020 · expires 2029-07-31ActiveNo board action on this licenceCheck it with the state
- Illinois 125067114Temporary Medical Permit · since 2018 · expires 2020-06-22Specialty on the licence: OtolaryngologyCancelledNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- National Jewish HealthDenver, COAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of National Jewish HealthNo overall ratingNo measure marked better or worse than the national rate
- Saint Joseph HospitalDenver, COAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Intermountain Healthcare, which runs 33 hospitals in 4 statesPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.119, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.507, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.19, Oct 2024 – Sep 2025
- University of Colorado Hospital AuthorityAurora, COAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of University of Colorado Health, which runs 12 hospitals in 2 statesHome of University of Colorado Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.33 (1.15 to 1.52), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.19 (2.14 to 4.24) · 2,906 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.54 (1.12 to 1.96) · 10,774 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.492, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.566, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.279, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 9 (7.8 to 10.5) · 1,332 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for National Jewish Health
Behind the star rating — Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.45) · 38 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.62 (0 to 1.96) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.2 to 7.4) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.9 to 13.4) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.3 (10.9 to 19) · 464 cases | No different | Jan 2022 – Dec 2024 |
See every measure and the patient survey for Saint Joseph Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.119 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.507 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.19 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.14 to 2.15) · 437 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.67 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.5 · 34 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.9 · 29 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.2 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.7 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 104 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 2,837 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 2,022 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,276 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.07 (0.76 to 5.38) · 702 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.32 (0 to 2.87) · 413 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.58 to 3.68) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.53 (0 to 13.11) · 366 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.34 (0.71 to 7.97) · 412 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.17) · 150 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.28 (0.39 to 2.18) · 1,660 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 83 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.337 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.687 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.778 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.3 · 563 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 17.8 · 125 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33 · 122 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 398 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.3 to 8.2) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (7.6 to 15.8) · 26 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 79 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.4 to 17.5) · 48 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 147 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,155 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
See every measure and the patient survey for University of Colorado Hospital Authority
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 1 better, 10 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.33 (1.15 to 1.52) | Worse | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 3.19 (2.14 to 4.24) · 2,906 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.54 (1.12 to 1.96) · 10,774 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.492 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.566 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.279 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (7.8 to 10.5) · 1,332 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.58 to 1.98) · 3,487 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 175.29 (144.06 to 206.51) · 400 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 79 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 136 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.9 · 317 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.8 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 366 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.4 · 5,078 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.09 to 0.44) · 11,709 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 13,154 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.43 (2.12 to 4.74) · 5,027 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (1.25 to 3.33) · 4,375 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.4 (7.01 to 13.78) · 2,655 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.8 (2.76 to 6.83) · 2,855 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.57 (0.34 to 2.79) · 1,608 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 88 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.59 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.29 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.896 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 199 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.1 · 530 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 5.9 · 113 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -12.2 · 364 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 11.1 · 461 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 655 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.7 to 6.9) · 1,332 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 85 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.1 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 277 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12 (9.5 to 15.1) · 2,456 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 1,478 cases | No different | Jan 2024 – Dec 2024 |
What patients said (5,233 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$77,735
Medicare paid this office $77,735 for 177 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of growth of pituitary using an endoscope | 12 | $9,495 | $791 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 35 | $8,860 | $148 |
| Diagnostic exam of nasal passages using an endoscope | 140 | $8,341 | $50 |
| Long return visit (40+ min) | 54 | $6,967 | $111 |
| New patient visit (45+ min) | 46 | $4,920 | $107 |
See all 11 services
| Removal of growth of pituitary using an endoscope | 12 | $9,495 | $791 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 35 | $8,860 | $148 |
| Diagnostic exam of nasal passages using an endoscope | 140 | $8,341 | $50 |
| Long return visit (40+ min) | 54 | $6,967 | $111 |
| New patient visit (45+ min) | 46 | $4,920 | $107 |
| Return visit (30+ min) | 39 | $3,829 | $74 |
| Removal of nasal sinus tissue using an endoscope | 15 | $3,068 | $205 |
| Computer-assisted procedure outside membrane covering brain | 20 | $2,697 | $135 |
| Short return visit (20+ min) | 34 | $2,158 | $51 |
| New patient visit (60+ min) | 11 | $1,500 | $136 |
| New patient visit (30+ min) | 11 | $610 | $55 |
Who their Medicare patients are
177 Original Medicare patients in 2024. Average age 72 · Women 54% · Also on Medicaid 15% · Health risk score 1.51. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 65% · COPD 38% · Coronary heart disease 32% · Depression 26% · Diabetes 25% · Chronic kidney disease 20% · Cancer 15% · Heart failure 14% · Atrial fibrillation 14% · Stroke 7%.
The office billed $713,263, Medicare allowed $99,622 and paid $77,735; for 595 services of 39 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 177 | 595 | 72 | 1.51 | $713,263 | $77,735 |
| 2023 | 141 | 503 | 71 | 1.29 | $500,696 | $62,869 |
| 2022 | 101 | 371 | 70 | 1.29 | $408,225 | $55,890 |
| 2021 | 109 | 212 | 69 | 1.47 | $131,174 | $19,915 |
| 2020 | 18 | 27 | 71 | 1.05 | $2,789 | $1,092 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Long return visit (40+ min) | 58 | $8,368 | $112 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 32 | $7,843 | $157 |
| Diagnostic exam of nasal passages using an endoscope | 116 | $7,807 | $50 |
| New patient visit (45+ min) | 35 | $3,770 | $108 |
| New patient visit (60+ min) | 27 | $3,726 | $138 |
| Return visit (30+ min) | 26 | $2,925 | $77 |
| Computer-assisted procedure outside membrane covering brain | 11 | $1,537 | $140 |
| Short return visit (20+ min) | 13 | $801 | $53 |
2022: 5 services
| Biopsy or removal of nasal polyp or tissue using an endoscope | 28 | $7,123 | $166 |
| Long return visit (40+ min) | 42 | $6,144 | $118 |
| Diagnostic exam of nasal passages using an endoscope | 85 | $5,542 | $52 |
| New patient visit (45+ min) | 37 | $4,053 | $110 |
| Computer-assisted procedure outside membrane covering brain | 14 | $1,960 | $140 |
2021: 5 services
| Biopsy or removal of nasal polyp or tissue using an endoscope | 18 | $4,422 | $192 |
| Long return visit (40+ min) | 19 | $2,351 | $118 |
| Return visit (30+ min) | 26 | $2,245 | $83 |
| New patient visit (45+ min) | 17 | $2,126 | $125 |
| Diagnostic exam of nasal passages using an endoscope | 68 | $1,704 | $22 |
Medicaid work
$2,564 in 2024
Medicaid paid $2,564 for 40 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 40 | $2,564 |
| 2024 | 40 | 1 | 13 | $2,564 |
| 2023 | 163 | 2 | 17 | $9,940 |
| 2022 | 24 | 1 | 12 | $1,767 |
| 2021 | 12 | 1 | 12 | $522 |
See the largest Medicaid services in earlier years
2023
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 149 | $9,902 |
| Short return visit | 14 | $38 |
2022
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 24 | $1,767 |
2021
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 12 | $522 |
Drugs they prescribed that Part D paid
$10,205
Pharmacies billed $10,205 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (19 of 272) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
265 generic and fewer than 11 brand-name prescriptions · $10,205 in drug cost · 31 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 97 | $4,171 | $43 |
| Budesonide | 16 | $3,190 | $199 |
| Mupirocin | 41 | $652 | $16 |
| Azelastine | 16 | $390 | $24 |
| Fluticasone Propionate | 16 | $223 | $14 |
See all 7 drugs
| Ipratropium | 97 | $4,171 | $43 |
| Budesonide | 16 | $3,190 | $199 |
| Mupirocin | 41 | $652 | $16 |
| Azelastine | 16 | $390 | $24 |
| Fluticasone Propionate | 16 | $223 | $14 |
| Amoxicillin-Clavulanate Potass | 16 | $141 | $9 |
| Oxycodone | 16 | $29 | $2 |
Year by year
| 2024 | 272 | 104 | 7% (19) | None | $10,205 |
| 2023 | 204 | 67 | None | None | $9,888 |
| 2022 | 71 | 38 | 16% (11) | 0% | $1,885 |
| 2021 | 132 | 53 | 8% (11) | None | $5,474 |
| 2020 | 37 | 17 | None | None | $661 |
| 2019 | 58 | 35 | None | None | $1,462 |
| 2018 | 49 | 34 | 33% (16) | None | $728 |
| 2017 | 68 | 33 | 38% (26) | None | $1,953 |
| 2016 | 70 | 29 | 23% (16) | None | $2,526 |
| 2015 | 15 | 13 | None | 0% | $135 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Mometasone Furoate | 15 | $3,833 | $256 |
| Ipratropium | 44 | $2,292 | $52 |
| Azelastine | 18 | $593 | $33 |
| Mupirocin | 38 | $378 | $10 |
| Amoxicillin-Clavulanate Potass | 14 | $186 | $13 |
| Fluticasone Propionate | 16 | $173 | $11 |
| Prednisone | 13 | $33 | $3 |
2022: 1 drug
| Azelastine | 17 | $533 | $31 |
2021: 2 drugs
| Azelastine | 51 | $2,442 | $48 |
| Ipratropium | 14 | $804 | $57 |
2019: 1 drug
| Fluticasone Propionate | 17 | $87 | $5 |
2018: 1 drug
| Hydrocodone-Acetaminophen | 14 | $153 | $11 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 21 | $402 | $19 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 16 | $410 | $26 |
Money from drug and device companies
$6,033 in 2025
| 2025 | 6 | 13 | $5,460 | $6,033 |
| 2024 | 5 | 21 | $16,000 | $17,408 |
| 2023 | 2 | 8 | $806 | $1,430 |
| 2022 | 3 | 5 | $406 | $792 |
| 2021 | 1 | 1 | None | $24 |
| 2020 | 2 | 2 | None | $267 |
| 2019 | 3 | 13 | None | $1,640 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Regeneron Pharmaceuticals | Dupixent | $5,460 | 2 payments
|
| Integra LifeSciences | Acclarent Aera | $216 | 5 payments
|
| Medtronic | Propel | $161 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | None | $112 | 1 payment
|
| Genzyme | Dupixent | $44 | 1 payment
|
| GlaxoSmithKline | Nucala | $40 | 1 payment
|
See all 13 published payments
| Regeneron Pharmaceuticals | Consulting · 2025-11-21 | Dupixent | $1,820 |
| Regeneron Pharmaceuticals | Consulting · 2025-11-21 | Dupixent | $3,640 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-05 | None | $112 |
| Medtronic | Meals · 2025-07-23 | Propel | $59 |
| Integra LifeSciences | Meals · 2025-07-11 | Acclarent Aera | $24 |
| Integra LifeSciences | Meals · 2025-07-11 | Acclarent Aera | $90 |
| Integra LifeSciences | Meals · 2025-07-10 | Acclarent Aera | $53 |
| Integra LifeSciences | Meals · 2025-03-20 | Acclarent Aera | $21 |
| Integra LifeSciences | Meals · 2025-03-20 | Acclarent Aera | $28 |
| Genzyme | Meals · 2025-02-07 | Dupixent | $44 |
| Medtronic | Meals · 2025-02-03 | Propel | $28 |
| GlaxoSmithKline | Meals · 2025-02-02 | Nucala | $40 |
| Medtronic | Meals · 2025-01-27 | Propel | $74 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $17,408
| GlaxoSmithKline | Nucala | $17,155 | 17 payments
|
| Aerin Medical | Vivaer Stylus | $147 | 1 payment
|
| Genzyme | Dupixent | $45 | 1 payment
|
| Integra LifeSciences | Acclarent Aera | $41 | 1 payment
|
| Stryker | Clarifix Cryotherapy Device | $20 | 1 payment
|
2023: $1,430
| Aerin Medical | Vivaer Stylus | $1,087 | 5 payments
|
| Medtronic | Propel | $342 | 3 payments
|
2022: $792
| Aerin Medical | None | $591 | 3 payments
|
| Medtronic | Propel | $136 | 1 payment
|
| GlaxoSmithKline | Nucala | $65 | 1 payment
|
2021: $24
| Medtronic | Stealthstation | $24 | 1 payment
|
2020: $267
| Stryker | Entellus - Xpress Ent Dilation System | $174 | 1 payment
|
| Olympus Corporation of the Americas | Pk Diego | $93 | 1 payment
|
2019: $1,640
| Olympus Corporation of the Americas | Pk Diego | $1,115 | 9 payments
|
| Intersect ENT | Propel | $386 | 3 payments
|
| Stryker | Entellus - Xpress Ent Dilation System | $139 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| GlaxoSmithKline, LLC. · A Randomised, Double-Blind, Parallel Group Phase III Study To Assess T · 2023 | Their institution | $32,160 |
| GlaxoSmithKline, LLC. · A Randomised, Double-Blind, Parallel Group Phase III Study To Assess T · 2024 | Their institution | $732 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1174917371
- Licence
- CA 170474, CO CDR.0001509, IL 036153049, IL 125.067114California A170474: Current · expires 2028-10-31Colorado CDR.1509: ActiveIllinois 036153049: ActiveIllinois 125067114: Cancelled
- Trained
- University of Chicago, Pritzker School of Medicine, 2015
- Group
- University Physicians Incorporated · National Jewish Health
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 12631 E 17th Ave # Msb205, Aurora, CO, 80045
- NPI first listed
- 2015-03-25
- NPI last updated
- 2025-02-18
- NPI record certified
- 2025-02-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1400 Jackson St, Denver, CO, 80206 · 777 Bannock St, Denver, CO, 80204 · 801 Welch Rd, Palo Alto, CA, 94304
This office lists an electronic records connection.